Constellation Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/12/2024
Constellation Pharmaceuticals Stock Forecast and Price Target
Constellation Pharmaceuticals's stock price reaches the average target of $54.50 by 2025 as expected recently by three notable experts, there would be a potential upside of approximately 60.34% from the last closing price in July, 2021. This possible increase is based on a high estimate of $75.00 and a low estimate of $34.00. If you're looking for Constellation Pharmaceuticals (CNST) stock information, you might also want to check out Amgen (NasdaqGS:AMGN).
60.34% Upside
Constellation Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Constellation Pharmaceuticals's Price has grown, increasing from $0.00 to $0.00 – a growth of 100.00%. The next year looks promising for Constellation Pharmaceuticals, with analysts predicting Fair Value of $36.41 – an increase of 100.00%. Over the next seven years, experts anticipate that Constellation Pharmaceuticals's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABBV Stock Forecast | AbbVie | Outperform |
9
|
$160.75 | Buy/Sell | $178.42 | 11.98% |
| AMGN Stock Forecast | Amgen | Outperform |
4
|
$310.15 | Buy/Sell | $303.65 | 3.18% |
| GILD Stock Forecast | Gilead Sciences Inc | Outperform |
11
|
$65.96 | Buy/Sell | $87.82 | 21.29% |
| ALXN Stock Forecast | Alexion Pharmaceuticals | - |
0
|
$182.50 | Buy/Sell | $177.38 | -100.00% |
| BIIB Stock Forecast | Biogen | Outperform |
10
|
$221.50 | Buy/Sell | $299.62 | 30.25% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BMRN Stock Forecast | BioMarin Pharmaceutical | Outperform |
10
|
$81.03 | Buy/Sell | $111.56 | 35.75% |
| INCY Stock Forecast | Incyte | Outperform |
9
|
$53.06 | Buy/Sell | $77.05 | 47.95% |
| VKTX Stock Forecast | Viking Therapeutics | Buy |
5
|
$73.64 | Buy/Sell | $34.00 | 56.17% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BPMC Stock Forecast | Blueprint Medicines | Outperform |
6
|
$106.70 | Buy/Sell | $85.71 | 12.00% |
| ARNA Stock Forecast | Arena Pharmaceuticals | - |
6
|
$99.99 | Buy/Sell | $100.00 | -100.00% |
| IOVA Stock Forecast | Iovance Biotherapeutics | Buy |
4
|
$10.97 | Buy/Sell | $20.42 | 132.45% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CCXI Stock Forecast | ChemoCentryx | - |
8
|
$51.99 | Buy/Sell | $52.00 | -100.00% |
| CBAY Stock Forecast | CymaBay Therapeutics | Hold |
8
|
$32.44 | Buy/Sell | $27.73 | -100.00% |
| ARWR Stock Forecast | Arrowhead Pharmaceuticals | Outperform |
7
|
$22.08 | Buy/Sell | $52.00 | 149.09% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DRNA Stock Forecast | Dicerna Pharmaceuticals | - |
7
|
$38.01 | Buy/Sell | $35.06 | -100.00% |
| FOLD Stock Forecast | Amicus Therapeutics | Outperform |
7
|
$9.23 | Buy/Sell | $17.90 | 105.85% |
| CLDX Stock Forecast | Celldex Therapeutics | Buy |
11
|
$39.92 | Buy/Sell | $63.29 | 77.86% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ACAD Stock Forecast | ACADIA Pharmaceuticals | Outperform |
6
|
$15.25 | Buy/Sell | $33.78 | 83.61% |
| VCEL Stock Forecast | Vericel | Buy |
8
|
$48.10 | Buy/Sell | $42.58 | 16.42% |
| ADMA Stock Forecast | ADMA Biologics | Buy |
9
|
$8.81 | Buy/Sell | $6.00 | 13.51% |
Constellation Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Constellation Pharmaceuticals's EPS has grown, increasing from $0.00 to $0.00 – a growth of 100.00%. The next year looks promising for Constellation Pharmaceuticals, with analysts predicting EPS of $0.00 – an increase of 100.00%. Over the next seven years, experts anticipate that Constellation Pharmaceuticals's EPS will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ARDX Stock Forecast | Ardelyx | Buy |
11
|
$7.77 | Buy/Sell | $9.94 | 80.18% |
| AGIO Stock Forecast | Agios Pharmaceuticals | Outperform |
9
|
$33.00 | Buy/Sell | $40.00 | 34.85% |
| DVAX Stock Forecast | Dynavax Technologies | Outperform |
11
|
$10.73 | Buy/Sell | $25.00 | 128.33% |
Site Navigation
.jpg)